Stock Market Reviews

Read and share opinions on ARMP (Armata Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

Latest News

• Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
  Nov 12, 2025
• Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
  Nov 12, 2025
• Armata Pharmaceuticals Announces Formal Commissioning of State-of-the-Art cGMP Phage Manufacturing Facility in Los Angeles, California
  Nov 10, 2025
• Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains?
  Oct 23, 2025
• Armata Pharmaceuticals Highlights Positive Results from Phase 2a diSArm Study of its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, in Late-Breaking Oral Presentation at IDWeek 2025™
  Oct 22, 2025
• Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™
  Oct 14, 2025
• Are Medical Stocks Lagging Armata Pharmaceuticals (ARMP) This Year?
  Oct 6, 2025
• Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
  Sep 18, 2025
• Armata Pharmaceuticals Announces Structural Biology Publication in the Journal of Molecular Biology
  Sep 8, 2025
• Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 4, 2025
• Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
  Sep 1, 2025
• All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy
  Aug 15, 2025
• Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?
  Aug 15, 2025
• Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates
  Aug 12, 2025
• Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update
  Aug 12, 2025
• Armata Pharmaceuticals Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia
  May 19, 2025
• Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update
  May 14, 2025